Novavax Inc expects petitioning for endorsement of its COVID-19 immunization up-and-comer in the United States in December, Chief Executive Stanley Erck said in a meeting for Czech every day Hospodarske Noviny, delivered on Thursday.

The organization intends to create part of the antibody at its Czech plant, which will give the nation admittance to the item once it is endorsed, the paper referred to Erck as saying.

Novavax said on Monday it had started enlisting volunteers for the second period of a progressing clinical preliminary of its COVID-19 antibody up-and-comer, with between time information expected in the final quarter of 2020.